Treatment of Biliary Gastritis
The most effective treatment for symptomatic biliary gastritis is surgical diversion of bile away from the gastric mucosa using a Roux-en-Y reconstruction, as medical therapy has consistently proven ineffective for this condition. 1, 2, 3
Medical Management Limitations
Medical therapy for biliary gastritis has been disappointing and largely ineffective:
- Bile acid chelating agents (cholestyramine) and prokinetic drugs fail to provide meaningful symptom relief in most patients 1, 2
- Antacids and dietary modifications frequently aggravate rather than improve symptoms 1
- While cholestyramine can bind 97-100% of bile acids in vitro at various pH levels, this does not translate to clinical efficacy in vivo 4
- Conservative management should be attempted initially, but surgery should be considered when symptoms persist for at least 2 years despite medical treatment and significantly affect quality of life 3
Surgical Treatment Approach
Primary Biliary Gastritis (Without Prior Gastric Surgery)
For patients with primary biliary gastritis (often associated with prior cholecystectomy), Roux-en-Y choledochojejunostomy without gastric resection or vagotomy is the procedure of choice:
- This approach achieves complete symptom relief in 87% of patients 2
- No operative mortality and minimal long-term complications (no anastomotic strictures) 2
- Gastric emptying remains normal or improves in the majority of patients (63% improvement in those with preoperative abnormalities) 2
- Self-limited bile leaks occur rarely but resolve without intervention 2
Post-Gastrectomy Biliary Gastritis
For patients with biliary reflux gastritis following gastric surgery (Billroth II, vagotomy with gastrojejunostomy, or pyloroplasty):
- Roux-en-Y reconstruction is the standard surgical diversion procedure 1, 3, 5
- The Tanner 19 modification (Roux-19 procedure) may reduce the incidence of delayed gastric emptying complications 1, 3
- Early results show excellent pain relief (84%) and resolution of bilious vomiting (96%) 3
- Long-term results demonstrate excellent or good outcomes in 87% of patients 3
Common Pitfalls and Complications
Roux stasis syndrome is the most frequent complication following Roux-en-Y reconstruction:
- Occurs in approximately 35-40% of patients 3
- Despite this complication, quality of life is significantly improved in most patients 3
- The Tanner 19 modification may help reduce this complication rate 1
Other surgical considerations:
- Operative mortality is low (approximately 3.8%) 3
- Overall morbidity is approximately 57%, but most complications are manageable 3
- Careful patient selection is essential to achieve satisfactory results 3
Diagnostic Confirmation Before Surgery
Diagnosis should be confirmed by:
- Typical symptoms: epigastric pain, bilious vomiting, weight loss, and nausea 1, 2, 3
- Endoscopic visualization of bile reflux and gastritis 1, 3
- Histological documentation of gastritis severity (mild, moderate, or severe) 3
- Note that endoscopic and histological findings support but are not specific for the diagnosis 1
Treatment Algorithm
- Initial conservative management with medical therapy (cholestyramine, prokinetics) for symptomatic patients 1, 3
- If symptoms persist for ≥2 years and significantly impair quality of life despite medical treatment, proceed to surgical evaluation 3
- For primary biliary gastritis: Roux-en-Y choledochojejunostomy without gastric resection 2
- For post-gastrectomy biliary gastritis: Roux-en-Y reconstruction or Tanner 19 modification 1, 3
Histological changes may persist after surgery despite symptom improvement, so clinical response rather than histological resolution should guide assessment of surgical success 3